Approval · Notice of Compliance 33822 · 2024
ARESTIN MICROSPHERES: Notice of Compliance 33822
Issued August 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33822
- Date
- August 15, 2024
- Company
- Ora Pharma Inc.Bridgewater, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information. Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARESTIN MICROSPHERES | Not yet assigned | — |
Medicinal ingredients
- MINOCYCLINE HCL 1 MG per 4MG